Our results also demonstrated strongly higher BIRC5 expression in basal-like and triple-negative breast cancer patients with respect to non-basal-like and non-triple-negative patients (Figure 4H,I and Table 1). This evidence concerns the gene BIRC5 and triple-negative breast carcinoma.